...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats.
【24h】

Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats.

机译:黄芪总苷对大鼠肝纤维化的影响及其机制。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Astragalosides is the major active constituent of Radix Astragali. The present study was carried out to investigate the effect of crude astragalosides fraction (CAF) on rats liver fibrosis and its possible mechanisms. Hepatic fibrosis was induced by subcutaneous injection with 50% CCl(4) in Sprague-Dawley rats. The amount of CCl(4) administered was 1 mg kg(-1). The alanine aminotransferase (ALT), aspartate aminotransferase (AST) levels in plasma and hydroxyproline (Hyp), malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) contents in liver tissue were assayed by spectrophotometry. The hyaluronic acid (HA) and procollagen III (PC III) were assessed by radioimmunoassay. Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta1 (TGF-beta1) levels in culture supernatants of Kupffer cells (KCs) were determined with ELISA. Liver samples collected after 8 weeks of CCl(4) treatment were stained with hematoxylin-eosin (HE) and massion, and scored. Intragastric administration of CAF (10, 20 and 40 mg kg(-1)) significantly decreased indices of liver and spleen, the serum transaminase activities, HA and PC III levels, and Hyp and MDA contents in liver tissue in rats of hepatic fibrosis. Decreased SOD and GSH-px levels were reversed after administration of CAF. Histopathological scores showed CAF had inhibitory effect on the progression of hepatic fibrosis. In the in vitro experiments, CAF significantly reduced TNF-alpha and TGF-beta1 levels in culture supernatants of KCs. The results showed CAF significantly inhibited the progression of hepatic fibrosis induced by CCl(4), and the inhibitory effect of CAF on hepatic fibrosis might be associated with its ability to scavenge free radical and inhibit the production of TNF-alpha and TGF-beta1 from activated KCs.
机译:黄芪总苷是黄芪的主要活性成分。本研究旨在研究粗制黄芪总苷(CAF)对大鼠肝纤维化的影响及其可能的机制。通过在Sprague-Dawley大鼠中皮下注射50%CCl(4)诱导肝纤维化。 CCl(4)的给药量为1 mg kg(-1)。用分光光度法测定血浆中丙氨酸氨基转移酶(ALT),血浆中天冬氨酸氨基转移酶(AST)和羟脯氨酸(Hyp),丙二醛(MDA),超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-px)的含量。透明质酸(HA)和胶原蛋白III(PC III)通过放射免疫分析进行评估。用ELISA测定库普弗细胞(KCs)培养上清液中的肿瘤坏死因子-α(TNF-α)和转化生长因子-β1(TGF-β1)水平。 CCl(4)处理8周后收集的肝样品用苏木精-曙红(HE)和肿块染色,并评分。肝内给予CAF(10、20和40 mg kg(-1))可以显着降低肝纤维化大鼠肝脏和脾脏的指标,血清转氨酶活性,HA和PC III水平以及肝组织中Hyp和MDA含量。服用CAF后,SOD和GSH-px降低的水平被逆转。组织病理学评分显示,CAF对肝纤维化的进展具有抑制作用。在体外实验中,CAF显着降低了KCs培养上清液中的TNF-α和TGF-beta1水平。结果表明,CAF显着抑制了CCl(4)诱导的肝纤维化进程,并且CAF对肝纤维化的抑制作用可能与其清除自由基的能力和抑制TNF-α和TGF-β1的产生有关。激活的KC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号